Cailing Ma

Cailing Ma


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2013 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
ZCZhifang Chen
Zhifang Chen
JDJianbing Ding
Jianbing Ding
NPNannan Pang
Nannan Pang
RDRong Du
Rong Du
WMWei Meng
Wei Meng
YDYan Ding
Yan Ding
Background: The fine balance of Th17/Treg is crucial for maintenance of immune homeostasis. The objective of this study was to investigate the balance of Th17/Treg and the expression of related cytokines in Uighur cervical cancer patients. Methods: Peripheral blood was collected from 65 cases of cervical cancer patients, 42 cases of cervical CIN patients and 40 healthy people. Flow cytometry was used to detect the percentages of T cell subsets, including CD3+ T cells, CD4+ T cells, CD8+ T cells, Treg cells and Th17 cells. ELISA assay was conducted to detect expression levels of TGF-β, IL-6, IL-10, IL-17, IL-23 and IFN-γ. Results: There were no significant difference in the levels of CD3+ T cells, CD4+ T cells, CD8+ T cells, and the ratio of CD4+/CD8+ among the cervical cancer group, the CIN group and the healthy control group. However, compared with the healthy control group, the percentages of CD4+ CD25+ Treg, CD4+CD25+CD127- Treg, CD4+IL17+ Th17, CD4+CD25+Foxp3+, CD4+CD25- Foxp3+, CD8+CD25+CD127-Treg and CD8+CD25+Foxp3 were significantly higher in the cervical cancer group and the CIN group. Similar results were also found in the Th17/Treg ratio and the related cytokines. There was no significant difference between the cervical cancer group and the CIN group. Additionally, Th17 cell levels were positively correlated with IL-6, IL-23 and IL-17. Also, Treg cell levels were positively correlated with TGF-β, IL-10 and IL-6. Contrarily, Treg cell levels and IFN-γ were negatively correlated. Conclusions: Our data indicated that the Th17/Treg balance was broken in peripheral blood of cervical cancer patients. Analysis of Th17/Treg balance may have a significant implication in diagnosing cervical cancer. Virtual slides: The virtual slide for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1813823795931511

11 June 2021 in RSC Advances
Verified
Journal Article
Open access
PDF file
SCShuang Chen
Shuang Chen
LZLijun Zhu
Lijun Zhu
ZDZhong Du
Zhong Du
RMRong Ma
Rong Ma
TYTing Yan
Ting Yan
CMCailing Ma
Cailing Ma
Photothermal therapy (PTT) is a popular tumor therapy method, which is based on efficient photothermal nanoagents (PTNs). Clinical Indocyanine Green (ICG), as a Food and Drug Administration (FDA) approved agent, is an often-used PTN, meanwhile it is also a good near-infrared (NIR) fluorescence contrast agent. However, the further applications of ICG in biomedical fields are limited due to its poor stability. In this study, ICG was encapsulated by the amphiphilic polymer poly(styrene-co-maleic anhydride) (PSMA) to form ICG@PSMA nanoparticles. Furthermore, optical and thermal characteristics of ICG@PSMA nanoparticles were studied in detail. Strong NIR fluorescence and excellent photothermal properties of ICG@PSMA nanoparticles under 808 nm laser irradiation were measured. Besides, favorable biocompatibility of ICG@PSMA nanoparticles was demonstrated on a human cervical cancer cell line (HeLa) via cell viability studies. Hence, ICG@PSMA nanoparticles were further applied to enhanced PTT of living HeLa cells under 808 nm excitation, and a high PTT efficiency of ∼70% was obtained. The novel ICG nanoparticles as a promising PTT nanoplatform could offer an opportunity for further tumour treatments.

28 April 2014 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
YCYanxia Chen
Yanxia Chen
CMCailing Ma
Cailing Ma
WZWei Zhang
Wei Zhang
ZCZhifang Chen
Zhifang Chen
LMLi Ma
Li Ma
This study is to investigate the role of miR-143 expression in cervical squamous cell carcinoma (SCC). The expression level of miR-143 was examined by quantitative real-time PCR. Human papillomavirus (HPV) genotype was detected by HPV genotype detection kit. The expression level of bcl-2 was detected by immunohistochemistry. The positive rate of HPV was 78% in the patients of cervical SCC. The most prevalent genotype was HPV16, with a positive rate of 42%. The expression level of miR-143 was significantly lower in the cervical SCC tissues than that in the normal cervical tissues (Z=-2.180, P=0.029). Down-regulated miR-143 expression was associated with tumor size, lymph node metastasis and HPV16 infection in cervical cancer patients. No significant associations were found between the expression levels of miR-143 and age, clinical stage, differentiation or lymph vascular space invasion. And, in cervical SCC patients after treatment with Taxol chemotherapy, the expression level of miR-143 was higher and the positive expression of bcl-2 protein was lower. However, the differences in expression changes of miR-143 and bcl-2 were not statistically significant (miR-143, Z=-0.763, P=0.446; bcl-2 protein, χ2=2.277, P=0.131). Down-regulated miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical SCC, but miR-143 does not participate in the Taxol sensitivity response. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1401279451112150.

11 August 2022 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
ZDZhong Du
Zhong Du
RMRong Ma
Rong Ma
SCShuang Chen
Shuang Chen
HFHuimin Fan
Huimin Fan
YHYouqiang Heng
Youqiang Heng
CMCailing Ma
Cailing Ma
Photothermal therapy (PTT) is a safe and efficient anti-tumor treatment. A photothermal agent (PTA) with good biocompatibility and strong photothermal properties is of great importance for PTT. In this study, near-infrared (NIR) excitable clinical indocyanine green (ICG) was utilized as a PTA and further encapsulated by another PTA polydopamine (PDA) to form highly stable and efficient ICG@PDA nanoparticles (NPs). Then the ICG@PDA NPs were modified with methoxy polyethylene glycol amine (mPEG2000-NH2) to form biocompatible ICG@PDA@PEG NPs. ICG@PDA@PEG NPs showed good water solubility and a spherical shape with an average size of 140 nm. Furthermore, the photothermal properties of ICG@PDA@PEG NPs were studied and excellent photothermal performance with a photothermal conversion efficiency of 43.7% under 808 nm laser irradiation was achieved. Then, the PTT properties of ICG@PDA@PEG NPs were confirmed on HeLa cells with an efficiency of 86.1%. Meanwhile, the in vivo biocompatibility and toxicity of ICG@PDA@PEG NPs were evaluated. No apparent in vivo toxicity was observed in 24 hours and 7 days. Next, in vivo PTT analysis was conducted for cervical tumor-bearing nude mice under 808 nm laser excitation. It showed a good anti-tumor effect in vivo. Thus, ICG@PDA@PEG NPs exhibited great potential for safe and efficient photothermal therapy in anti-tumor therapy.

1 July 2024 in Journal of the Chinese Medical Association
Verified
Journal Article
Open access
ZLZao-Ling Liu
Zao-Ling Liu
NCNan Chen
Nan Chen
RLRong Li
Rong Li
YMYing-Jie Ma
Ying-Jie Ma
AQAerna Qiayimaerdan
Aerna Qiayimaerdan
CMCailing Ma
Cailing Ma
Background: Cancer-associated fibroblasts (CAFs) are crucial components of the cervical cancer tumor microenvironment, playing a significant role in cervical cancer progression, treatment resistance, and immune evasion, but whether the expression of CAF-related genes can predict clinical outcomes in cervical cancer is still unknown. In this study, we sought to analyze genes associated with CAFs through weighted gene co-expression network analysis (WGCNA) and to create a predictive model for CAFs in cervical cancer. Methods: We acquired transcriptome sequencing data and clinical information on cervical cancer patients from the cancer genome atlas (TCGA) and gene expression omnibus (GEO) databases. WGCNA was conducted to identify genes related to CAFs. We developed a prognostic model based on CAF genes in cervical cancer using the least absolute shrinkage and selection operator (LASSO) Cox regression analysis. Single-cell sequencing data analysis and in vivo experiments for validation of hub genes in CAFs. Results: A prognostic model for cervical cancer was developed based on CAF genes including COL4A1, LAMC1, RAMP3, POSTN, and SERPINF1. Cervical cancer patients were divided into low- and high-risk groups based on the optimal cutoff value. Patients in the high-risk group had a significantly worse prognosis. Single-cell RNA sequencing data revealed that hub genes in the CAFs risk model were expressed mainly in fibroblasts. The real-time fluorescence quantitative polymerase chain reaction (PCR) results revealed a significant difference in the expression levels of COL4A1, LAMC1, POSTN, and SERPINF1 between the cancer group and the normal group (p < 0.05). Consistently, the results of the immunohistochemical tests exhibited notable variations in COL4A1, LAMC1, RAMP3, POSTN, and SERPINF1 expression between the cancer and normal groups (p < 0.001). Conclusion: The CAF risk model for cervical cancer constructed in this study can be used to predict prognosis, while the CAF hub genes can be utilized as crucial markers for cervical cancer prognosis.

21 January 2026 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
MAMaierhaba Aili
Maierhaba Aili
RMRong Ma
Rong Ma
YCYaqi Cui
Yaqi Cui
MAMeihaguli Abulaizi
Meihaguli Abulaizi
NANuernisha Alifu
Nuernisha Alifu
Biao DongBiao Dong
Biao Dong
Photodynamic therapy (PDT) has emerged as a minimally invasive therapeutic modality for cancer treatment. However, its clinical efficacy is constrained by two fundamental limitations: tumor hypoxia, resulting from insufficient oxygen availability, and restricted treatment depth due to limited tissue light penetration. Historically, nanomaterials served primarily as passive delivery vehicles for photosensitizer (PS) transport to tumor sites. Nevertheless, a paradigm shift has occurred in this domain, with nanomaterials evolving into active therapeutic platforms. This transformation can be conceptualized through a three-stage evolutionary model: (1) circumvention of limitations via strategies such as designing upconversion nanoparticles (UC NPs), (2) reversal of constraints through localized oxygen generation or Type I photoreactions, and (3) exploitation of limitations by inducing immunogenic cell death (ICD) to activate antitumor immunity. Recent advancements have introduced innovative approaches, including the development of novel Type I PSs, construction of smart nanosystems with molecular logic gates, and implementation of advanced techniques such as proteolysis-targeting chimera (PROTAC) delivery and pyroptosis induction. These strategies enable tumor microenvironment modulation, redefining nanoscale PDT as an immune priming engine capable of triggering systemic antitumor immune responses. When integrated with immunotherapy, enhanced abscopal effects are observed, leading to regression of untreated distal tumors. This review concludes by addressing clinical translation challenges and proposing future directions, including the development of closed-loop theranostic systems and personalized medicine frameworks.